Anthracycline-Induced Cardiotoxicity: Molecular Insights Obtained from Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes (hiPSC-CMs)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1550-7416
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Anthracycline-Induced Cardiotoxicity: Molecular Insights Obtained from Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes (hiPSC-CMs) ; volume:23 ; number:2 ; day:14 ; month:3 ; year:2021 ; pages:1-12 ; date:3.2021
The AAPS journal / American Association of Pharmaceutical Scientists ; 23, Heft 2 (14.3.2021), 1-12, 3.2021
- Urheber
-
Bozza, William P.
Takeda, Kazuyo
Alterovitz, Wei-Lun
Chou, Chao-Kai
Shen, Rong-Fong
Zhang, Baolin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1208/s12248-021-00576-y
- URN
-
urn:nbn:de:101:1-2021052820254820334071
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bozza, William P.
- Takeda, Kazuyo
- Alterovitz, Wei-Lun
- Chou, Chao-Kai
- Shen, Rong-Fong
- Zhang, Baolin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
Involvement of cardiac fibroblasts in anthracycline-induced cardiotoxicity
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Modeling anthracycline-induced cardiotoxicity with patient-specific iPSCs
Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
Anthracycline Chemotherapy and Cardiotoxicity
Characterization of anthracycline-induced cardiotoxicity by diffusion tensor magnetic resonance imaging
Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients
Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?
Evaluation of etoposide-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes
Detection of anthracycline-induced cardiotoxicity using perfusion-corrected 99mTc sestamibi SPECT
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
Involvement of cardiac fibroblasts in anthracycline-induced cardiotoxicity
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Modeling anthracycline-induced cardiotoxicity with patient-specific iPSCs
Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
Anthracycline Chemotherapy and Cardiotoxicity
Characterization of anthracycline-induced cardiotoxicity by diffusion tensor magnetic resonance imaging
Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients
Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?
Evaluation of etoposide-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes
Detection of anthracycline-induced cardiotoxicity using perfusion-corrected 99mTc sestamibi SPECT
Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes
Involvement of cardiac fibroblasts in anthracycline-induced cardiotoxicity
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Modeling anthracycline-induced cardiotoxicity with patient-specific iPSCs
Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
Precision Treatment of Anthracycline-Induced Cardiotoxicity: An Updated Review
Anthracycline Chemotherapy and Cardiotoxicity
Characterization of anthracycline-induced cardiotoxicity by diffusion tensor magnetic resonance imaging
Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients
Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?
Evaluation of etoposide-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes